慢性肾脏病(chronic kidney disease,CKD)影响着全球约 10% 的人口,全球疾病负担联盟预计到 2024 年,CKD 将成为影响人类寿命的五大疾病之一。CKD 患者患心血管疾病(cardiovascular disease,CVD)的风险显著增加,包括冠状动脉疾病、心衰、心律失常和心源性猝死。 美国肾脏数据系统(USRDS)2020 年的数据显示,CKD 患者的 CV...
CARDIOVASCULAR diseasesSEX factors in diseaseCHRONIC kidney failureNON-ST elevated myocardial infarctionAMBULATORY blood pressure monitoringThis article explores the impact of cardiovascular disease (CVD) on older women with chronic kidney disease (CKD). CKD is a global health concern, particularly affecting...
碱性磷酸酶——比PT..引言慢性肾脏病(chronic kidney disease,CKD)已成为危害人类健康的主要疾病之一。由心血管疾病(cardiovascular disease,CVD)引起的死亡占一半甚至更多。心
CKD 患者面临着沉重的疾病负担和经济负担。疾病负担方面:相较于非 CKD 人群,其发生冠心病、心衰、脑卒中等心血管疾病(cardiovascular disease,CVD)的风险显著升高,并且随着肾小球滤过率(estimated glomerular filtration rate,eGFR)的下降,CKD 患者全因死亡风险显著升高[2,3...
5. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J[J]. 2021 Sep 7;42(34):3227-3337. 6. 中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中华心血管病杂志编辑委员会. 超高危动脉粥样硬化性心血管疾病患者...
5.Phil McEwan, et al. ESTIMATING THE IMPACT OF DELAYED DISEASE PROGRESSION AND CARDIOVASCULAR EVENT INCIDENCE ASSOCIATED WITH DAPAGLIFLOZIN BASED ON THE RESULTS OF DAPA. Presented at AMCP 2021, Virtual meeting, 12 April 2021 –16 April 2021. ...
Cardiovascular (CV) disease remains a leading cause of death in CKD patients, who experience a high burden of hypertension, diabetes and CV comorbidity [5]. CV disease burden begins early in CKD, with eGFR <60 mL/min/1.73 m2 and albumin creatinine ratio 30 mg/g being associated with ...
1、CKD患者的传统与非传统心血管疾病的高危因素山东大学齐鲁医院肾脏科胡昭 裴斐(山东济南,250012)心血管疾病(cardiovascular disease , CVD是慢性肾脏疾病(chronic kidney disease,CKD)最常见的并发症,是 CKDS者最主要的死亡原因,CKDS 者可能在发生ESREfc前已经死于CVD终末期肾衰患者心血管病的死亡率是正 常人群的...
我国慢性肾脏病(Chronic Kidney Disease,CKD)呈上升趋势,患者的心血管事件的发生率仍然很高,临床表现也复杂多样,其原因可能是心血管疾病(Cardiovascular Disease,CVD)与CKD有相同的危险因素和病理生理基础,比如年龄、肥胖、糖尿病、高血压等。在临床中,sST2作为心力衰竭患者风险分层和预后评估的一种新型心脏标志物,能更...
2. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B...